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Y I001 
PROSTAGLANDIN E 2 AND INTERLEUKIN-6 PRODUCTION BY 
HUMAN SUBCHONDRAL OSTEOBLASTS CAN 
DISCRIMINATE TWO SUBGROUPS OF OSTEOARTHRITIC 
PATIENTS 
F. Massicotte, D. Lajeunesse, M. Benderdour, J. C. Fernandes, 
J.-P. Pelletier and J. MarteI-Pelletier 
Osteoarthritis Research Unit, Centre Hospitalier de I'Universite de 
Montreal, H6pital Notre-Dame, Montreal, Canada, H2L 4MI. 
Objectives: The cause of subchondral bone sclerosis in osteoar- 
thritis (OA) remains controversial but recent evidence with animal 
models suggest that it could precede cartilage damage. Both 
clinical and in vitro studies of human OA indicate altered bone 
metabolism and abnormal phenotypic features of subchondral 
osteoblasts (Ob) including elevated alkaline phosphatase activity, 
osteocalcin, urokinase piasminogen and plasmin activities, and 
insulin-like growth factor-1 levels. We questioned if the production 
of cytokines/factors involved in bone tissue remodeling, and 
possibly involved in the local integrity of the overlaying cartilage 
tissue, could show an abnormal pattern in OA Ob. 
Methods: Normal and OA Ob were isolated from tibial plateaus 
of patients at autopsy or undergoing total knee surgery, respect- 
ively. First passage Ob were used to determine the production of 
IL-I~, TGF-~, IL-6 and PGE2 using selective ELISA. The inter- 
relationship between PGE 2 and IL-6 production was investigated 
using selective inhibitors and/or inactivating antibodies. Pheno- 
typic features of Ob were also evaluated by the alkaline 
phosphatase activity and the secretion of osteocalcin. 
Results: OA Ob produced all three cytokines and PGE 2 albeit at 
higher and more variable levels than normal Ob. Interestingly, the 
results revealed the presence of two subgroups of OA patients 
based on the cytokine/PGE 2 production: low and high OA Ob 
responders. In low OA Ob, the level of cytokines and PGE~ was 
similar as in normal Ob. In contrast, in high OA Ob, levels were 
slightly elevated for IL-I~, and TGF-I~, whereas the levels were 
increased 5-fold for IL-6 and 2-fold for PGE 2 compared to normal. 
The production of PGE 2 by OA cells was responsible, in part, for 
the elevated IL-6 levels. Indeed, the incubation of OA cells with 
indomethacin and naproxen, which both inhibited PGE 2 levels in 
high OA Ob to similar levels, blocked IL-6 production. Similar 
treatments in low OA Ob failed to inhibit IL-6 production in 
response to naproxen whereas indomethacin had a small inhibitory 
effect. In contrast, inhibiting IL-6 activity or blocking IL-6 receptor 
via neutralizing antibodies failed to modify PGE 2 levels in both low 
and high OA Ob. Both parathyroid hormone (100 nM) and PGE2 
(500 nM) stimulation enhanced IL-6 levels to similar levels in both 
low and high OA Ob. Alkaline phosphatase activity and osteocalcin 
release, both elevated in OA cells compared to normal, were 
similar between the two groups and hence could not discriminate 
between low and high responders. 
Conclusions: These results indicate that cytokine and PGE 2 
production by OA Ob, not their phenotypic expression, can dis- 
criminate between two subpepulations of OA patients. An elevated 
COX-2 activity may be responsible for the elevated levels of both 
PGE 2 and IL-6 in high OA Ob but not in low OA Ob. This abnormal 
cytokine production in high OA Ob in addition to abnormal 
phenotypic features could then further promote abnormal bone/ 
cartilage remodeling in OA. 
Y I002  
IN VlVO INHIBITION OF TGF-p ACTIVITY BY SOLUBLE 
TYPE II TGF-I~ RECEPTOR 
A. Scharstuhl, P. van der Kraan, E. Vitters, W. van den Berg 
Department of Rheumatology, University Medical Centre 
Nijmegen, Nijmegen, The Netherlands 
Transforming Growth Factor- l} (TGF-I}) is considered to be a 
beneficial factor during cartilage repair. However, TGF-~ can also 
induce fibrosis and osteophytes. The objective of this study was to 
determine the effect of TGF-[~ inhibition in an experimental model 
of cartilage damage. TGF-I~ signalling starts with the binding of 
TGF-13 to the type II receptor, a constitutively active serine/ 
threonine kinase. This complex then binds the type I receptor, 
which is subsequently phosphorylated by the type II receptor. This 
results in phosphorylation of downstream mediators by the type I 
receptor. Since the binding of TGF-13 to the extracellular domain of 
the type II receptor is one of high affinity, the soluble TGF-# type II 
receptor, lacking cytoplasmic and membrane domains, was used 
as a TGF-I], antagonist. 
For the production of recombinant solRII the methylotropic yeast 
Pichia pastoris was used. To determine the in vivo activity of solRII, 
TGF-!3 (20 ng) solRII (20 ~g) or the combination TGF-~/solRII was 
injected in murine knee joints on days 1, 3 and 5. On day 7 after 
the last injection, knees were dissected and processed for routine 
histology. The papaine model was used to study the effect of 
systemic delivery of solRII. Therefore, Alzet osmotic pumps 
containing 10 mg of solRII, were placed i.p. in C57BI/6 mice. One 
day later, a 1.2% papaine solution was injected in the right knee 
joint. Knees were dissected on day 7 and processed for routine 
histology. 
The co-injection experiment showed that the solRII in combina- 
tion with TGF-I~ was able to reduce osteophyte formation when 
compared to injections of TGF-~ alone. Injections of solRII by itself 
did not result in any abnormalities. Having established the bio- 
logical activity of recombinant solRII, we tried to block endogenous 
TGF-13 via systemic administration of solRII during an experimental 
model of cartilage destruction. Injection of a 1.2% papaine solution 
led to a decrease in proteoglycan (PG) content, while no cell death 
was observed. Surprisingly, the most obvious result from the 
inhibition of TGF-13 via solRII administration was an increase in 
chondrocyte death. This phenomenon was most apparent in the 
patella region of the joint. Moreover, besides an increase in cell 
death, cartilage PG content was lower in solRII treated animals 
than in control animals. Although, TGF- I} is reported to be 
implicated in fribrosis, no apparent differences in fibrosis were 
observed after administration of solRII. 
Recombinant solRll produced by Piehia pastoris is a biologically 
active protein, as is shown by the co-injection experiments. In 
these experiments, osteophyte formation induced by TGF-~ 
injections could be inhibited by solRII. An important role for TGF-13 
in the maintenance of cartilage PG content is suggested, because 
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systemic solRII treatment resulted in a decreased PG content in 
the papaine model. This reflects either impaired restoration of PG 
content or an increase in PG loss due to the inhibition of TGF-~. 
Furthermore, the results with the systemic delivery of solRII 
indicate that TGF-~, is an important factor in the regulation of 
chondrocyte death. This might be related to the inhibitory effects of 
TGF-I~ on NO synthesis. Whether or not the observed cell death is 
the result from apoptosis or necrosis, is currently under study. 
Y I003  
MUTATIONS IN TYPE IX AND TYPE Xl COLLAGEN IN 
PRIMARY OSTEOARTHRITIS (OA) 
Anthony M. ReginalD*t, Erik Spaydet, Leena Ala-Kokko:l:, Ajeya 
Joshi§, and Bjorn R. Olsent 
"Arthritis Unit, Massachusetts General Hospital; tDepartment of 
Cell Biology, §Harvard Combined Department of Orthopaedics 
Surgery, Harvard Medical School, Boston, U.S.A.; SDepartment of 
Medical Biochemistry, University of Oulu, Oulu, Finland 
Human osteoarthritis (OA) is a heterogeneous and muitifactorial 
disease characterized by the progressive degeneration of articular 
cartilages from both weight-bearing and nonweight-bearing joints. 
OA is clinically characterized by the progressive degradation of 
articular cartilage leading to joint space narrowing, osteophyte 
formation, subchondral sclerosis, cyst formation and joint destruc- 
tion. Several laboratories have shown evidence of genetic linkage 
to mutations in the type II procollagen gene in families with 
chondrodysplastic OA. However, recent epidemiologic analysis of 
affected sibpair and evaluation of affected families by OA have 
suggested that type II collagen mutations may not account for the 
large proportion of inherited OA. This data suggests that primary 
OA, characterized by early onset articular damage in the absence 
of significant joint trauma, may arise from alterations in other 
extracellular matrix components. To investigate this hypothesis, we 
have begun to examine whether mutations in the minor cartilage 
collagen genes are responsible for the genetic defect that underlie 
the more common forms of OA. We have examined a large 
population of patients (150) from the Brigham's and Women 
Hospital Total Joint Registry who required either total hip or knee 
joint arthroplasty for mutations in the minor cartilage collagen 
genes (COL9A1, COL9A2, COL9A3, COL11A1, and COL11A2). 
Patient cDNAs, obtained from EBV transformed lymphocytes were 
screened using single stranded conformational polymorphism 
(SSCP), and genomic DNA using conformational sensitive gel 
electrophoresis (CSGE) to look for mutations in type IX and type XI 
collagen genes. Of the 32 patients initially screened, one was 
found to have a heterozygous kipping mutation of exon 39 in the 
COL11A1 gene. The proband and the affected daughter had a 
single intronic base change of A ->G at position 17 within the 
3' intron/exon splice site responsible for the 108 bp exon skipping 
which coseggregated with shoulder/knee OA in this family. A 
second patient with knee OA was found to have a single base 
mutation that converted the codon of -GGC- for glycine at o~1-302 
to -AGC-, a codon for serine. The mutant COL9A1 allele was 
present in several of the affected members, but absent in one of 
the nonaffected members and coseggregated with knee OA in the 
family. 
These studies provide further evidence that mutations in the 
minor collagen genes, type IX and type XI genes, may lead to a 
spectrum of phenotypes with inherited primary OA. 
Y I004  
THE ASSOCIATION OF ALTERED BONE TURNOVER AND 
CALCIUM REGULATION WITH KNEE OSTEOARTHRITIS IN 
FEMALE TWINS 
D. J. Hunter', D. Hart*, T. Andrew*, H. Snieder*, A. J. MacGregor*, 
J. Meyert, P. Betticat, T. D. Spector ° 
"Twin Research and Genetic Epidemiology Unit, St Thomas' 
Hospital, London; ¢European R&D, P&G Pharmaceutical, Staines, 
United Kingdom 
Osteoarthritis is a disorder of the whole synovial joint organ. There 
is growing evidence of the importance of bone turnover, and 
human studies have demonstrated that the subchondral bone is 
metabolically active in osteoarthritis. The aim of this study was to 
assess the relationship between knee OA and altered bone 
turnover/calcium regulation. 
Methods: In the present study we performed a matched case- 
control study using twins discordant for OA. The subjects were 
1644 female Caucasian twin pairs (266 MZ and 556 DZ) aged 
18-71 years from the St Thomas' UK Adult Twin Registry. Assays 
for measures of bone turnover (bone specific alkaline phosphatase 
(bALP), osteocalcin (OC), and urinary deoxypyridinoline (DPD)), 
and calcium regulation (serum PTH, 25-OH-Vitamin D, serum 
calcium, serum magnesium, serum phosphate) were performed. 
The radiological features of knee OA were graded on a 4-point 
scale (0-3) for osteophytes and the Kellgren and Lawrence 
classification. Association of altered bone turnover/calcium regula- 
tion was tested after adjusting for age, body mass index and 
relatedness. Conditional logistic regression analysis for matched 
case control groups was used to estimate the odds ratio (OR) and 
95% confidence intervals (CI) for having radiological features of 
knee OA per standardized unit difference of serum variable, and 
adjusted for body mass index. Conditional logistic regression 
analysis with stepwise elimination for matched case-control groups 
was used to estimate the odds ratio (OR) for having radiological 
features of knee OA per standardized unit difference of bio- 
chemical variable. Further analysis was performed to assess the 
measures of bone turnover in subjects with knee OA, in com- 
parison to subjects in the lowest 10"/o for BMD with no knee OA, 
and control subjects. 
Results: 474 of the 1644 women studied had radiological 
evidence of knee osteophytes. There was evidence of increased 
bone turnover, increased PTH levels, and decreased Vitamin D 
levels in this group compared to those without osteophytes. After 
adjusting for age, BMI, and relatedness there was still a significant 
increase in bone resorption, as assessed by urinary DPD (p=0.04). 
Discordant twin pair analysis revealed non-significant increases in 
urinary DPD (OR 1.67 (0.68-3.16)), and significant decrease in 
serum magnesium (OR 0.65 (0.46-0.92)) in the co-twins with 
osteoarthritis. DPD levels in subjects with knee osteophytes were 
comparable to those in the lowest 10% of BMD, and greater than 
those in control subjects. Magnesium (OR 0.70(0.52-0.96)) and 
BMI (OR 1.22(1.12-1.32)) remained after-stepwise regression with 
backward elimination. 
Conclusions: Bone resorption, as measured by urinary DPD, in 
increased in women with knee osteoarthritis consistent with meta- 
bolically active subchondral bone. Bone formation markers, i.e. 
bALP and OC are not altered after adjusting for age and BMI 
effects. This finding might reflect an imbalance between bone 
resorption and formation in knee OA patients or may be due to the 
fact that the Iocalised nature of the bone remodelling in OA may not 
be reflected in these measures. All the calcium regulation markers 
were not altered after adjusting for age, with the exception of a 
significant increase in serum magnesium. Such a finding was 
unexpected and is worth examining further. 
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TH030 
PROSTAGLANDIN E 2 (PGE2) STIMULATION OF EARLY 
GROWTH RESPONSE GENE-1 (Egr-1) EXPRESSION IS 
MEDIATED BY A PROXIMAL cAMP-RESPONSIVE 
PROMOTER ELEMENT THROUGH ACTIVATION OF 
p38/STRESS-ACTIVATED PROTEIN KINASE-2A IN HUMAN 
SYNOVIAL FIBROBLASTS AND ARTICULAR 
CHONDROCYTES 
W. Fa£ur, Y. He, J. A. Di Battista 
Unite de Recherche en Arthrose, H6pital Notre-Dame du CHUM, 
Montreal, Canada 
Aim: We previously demonstrated that PGE 2 is a pleiotropic 
bioregulator that controls the expression of many genes (e.g. 
5-1ipooxygenase, tumour necrosis factor-oq etc.) associated with 
the pathophysiology of arthritis through the induction of the 
transcription factor egr-1/Krox-24. Our aim is to elucidate the 
signaling cascade which mediates the PGE2-dependent induction 
of the egr-1 gene. 
Methods: Human OA affected synoviocytes and chondrocytes 
were cultured to confluence, serum-starved for 6-8 h, and treated 
with PGE 2 and other effectors on a time and dose-dependence. 
Messenger RNA expression levels were monitored by Northern 
analysis while phosphorylated (activated) kinases and trans- 
cription factors were measured by Western blotting techniques 
using specific anti-phospho antibodies. Gel-shiff and super-gel 
shift analysis was used to confirm increases in nuclear transcrip- 
tion factor binding to cAMP-response element (CRE) oligo- 
nucleotides. Transient transfection analysis, using various egr-1 
promoter constructs and other kinase expression vectors in 
co-transfection, was also performed to further screen for PGE 2 
responsive elements in the 5' flanking sequences (promoter) of the 
egr-1 gene. 
Results: The induction of egr-1 mRNA by PGE 2 was time 
(maximal induction 30 min) and dose-dependent (ECso=75 nmol/ 
L) and was completely inhibited by SB203580 (p38/SAPK2cd~ 
inhibitor) and KT-5720 (protein kinase A inhibitor). Prostaglandin 
E 2 stimulated maximal p38/SAPK2od~ phosphorylation and acti- 
vation after 3-5 rain which was followed by an increase in 
phospho-CREB-1/ATF-1 (and ATF-2) after 5-10 min and reaching 
a zenith at 30 min. Gel-shift and super-gel shift analysis confirmed 
the PGE2-dependent increase in specific nuclear CRE binding 
proteins (i.e. phospho-CREB-1/AFT-1). Using wild-type (1395 
base pairs 5" flanking sequences) and deletion mutant egr-1 
promoter constructs under conditions of transient transfection, a 
proximal CRE site (-134 to -126) was necessary to mediate 
PGE 2 induction. Furthermore, PKAca~, MKK3 and p38/SAPK2cd~ 
overexpression ted to activation of the egr-I promoter and was 
also dependent on an intact CRE element. 
Conclusions: We conclude that egr-1 gene induction by PGE 2 
occurs through the activation of the MLK2/MKK3/p38/SAPK2od13 
pathway with the resultant rans-activation of the egr-1 promoter by 
CREB-1/ATF-1 through binding to the CRE site. This pathway 
provides an important new target for therapeutic intervention in the 
treatment of arthritic diseases. 
TH032 
A NOVEL MAGNETIC RESONANCE IMAGING METHOD TO 
DETECT PROTEOGLYCAN LOSS FROM CARTILAGE 
U. Du=vvuri, S. B. Kudchodkar, J. S. Leigh, R Reddy 
Department of Radiology, University of Pennsylvania, 
Philadelphia, PA, USA 
Aim: To determine whether proton magnetic resonance (MR) 
relaxation parameters can detect a small loss of proteoglycan from 
cartilage. We performed a longitudinal MR study on cartilage tissue 
subjected to serial enzymatic digestion to evaluate the ability of 
MR relaxation parameters to detect proteoglycan loss. 
Methods: Bovine patellae were obtained from a local butcher. 
Nine millimeter discs of cartilage were then cored and stored in 
phosphate buffered saline on ice. Proteoglycan depletion was 
performed with trypsin digestion (0.1 mg/ml) at 37°C for 1 and 
2 hours. The loss of proteoglycans from the tissue was quantified 
with a DMMB spectrophotometric assay. The collagen content of 
the tissue, following trypsin digestion, was also determined by 
measuring the amount of hydroxyproline lost from tissue with a 
HPLC method. At the end of the experiment, each tissue sample 
was minced and digested completely with papain for 12 hours. The 
percentage of macromolecules lost at each stage of the degrada- 
tion was determined by analyzing each aliquot and also the final 
degradation medium. 
All MR experiments were performed on a 2T magnet interfaced 
to a custom built console. MR relaxation parameters (T 1, T 2 and 
Th, ) were determined for each time point in the degradation. 
Results: All samples (n=5) demonstrated an increase in T1p after 
proteoglycan depletion (r2=0.83). Typically a 5% elevation of T h, 
was noted after 30% proteoglycan depletion. Collagen content 
was decreased by -1.5% by trypsin treatment. Therefore, TI~, 
relaxation appears to be a selective indicator for proteoglycan loss. 
All samples had elevated T 2 after initial proteoglycan depletion. 
However, 3/5 showed decreased T 2 after further depletion. T z was 
moderately correlated with proteoglycan loss (r2=0.76). However, 
T~, appears to be more correlated with progression of proteo- 
glycan loss. T~ was slightly increased after proteogtycan loss, and 
moderately correlated with changes in proteoglycan content 
(r2=0.61). 
Conclusions: TI~ ~ relaxation measurements appear to be sensi- 
tive to tissue proteoglycan content. Furthermore T~, increases, as 
proteoglycan is lost from the tissue in a longitudinal fashion. T1, ~ 
imaging may be useful in the longitudinal monitoring of cartilage 
disease. Further work is needed to evaluate the sensitivity and 
specificity of this technique. 
Acknowledgements: This research was performed at a NIH 
supported Resource Center (NIH RR02305) and supported by 
NIAMS-NIH grants AR45242, AR45404. 
TH033 
CHEMOKINES INDUCE HUMAN CHONDROCYTES TO 
RELEASE MATRIX DEGRADING ENZYMES 
I. Mazzetti °, R. M. Borzi*, S. Paoletti', L. Cattini*, M. Uguccionit, 
M. Baggiolinit, L. Frizziero:l: and A. Facchini'§ 
"Laboratorio di Immunologia e Genetica, Istituti Ortopedici Rizzofi, 
Bologna, Italy; t Theodore Kocher Institute, University of Bern, 
Switzerland; ~:Dip. Medico II, Centro di Reumatologia, Ospedale 
Maggiore, Bologna, Italy; §Diparfimento di Medfcina Intema e 
Gastroenterologia, Universita di Bologna, Italy 
Aim of the study: Chondrocytes control the integrity of the 
extracellular matrix and this function is influenced by cytokines 
present in the microenvironment of the joint. We previously 
demonstrated that human chondrocytes produce CC and CXC 
chemokines, and that their production is upregulated by IL-113 
and TNF. In this study we investigated if human chondrocytes 
possess chemokine receptors and the effects of chemokines on 
chondrocytes' activity. 
Methods: The expression of chemokines receptors was deter- 
mined by immunochemical analysis of frozen sections and by flow 
cytometry of cells isolated from normal (5 multiorgan donors) and 
osteoarthritic cartilage (17 OA patients). The messenger RNA 
expression for chemokine receptors was also studied by reverse 
transcription-polymerase chain reaction. Isolated chondrocytes 
were then stimulated with different chemokines. The response to 
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chemokines was evaluated assaying the release in the superna- 
tants of the matrix metalloprotease-3 (MMP-3), a key-enzyme in 
the breakdown of cartilage in vivo. The chemokine-induced release 
of the N-acetyl-13-D-glucosaminidase, a lysosomal enzyme degrad- 
ing glycosaminoglycans and hyaluronic acid, was also evaluated. 
Results: We found that chondrocytes express a surprisingly 
wide variety of chemokine receptors, CCR1, CCR2, CCR3, CCR5, 
CXCR1 and CXCR2 and that the interaction of these receptors 
with the corresponding ligands induces an abundant production 
and release of the matrix degrading enzymes. MMP-3 release was 
markedly enhanced by stimulation with MCP-1, RANTES and 
GROom, and this effect was similar to that obtained with IL-113. The 
chemokine-dependent release was abrogated by pre-treatment of 
the cells with B. pertussis toxin, demonstrating involvement of 
receptors coupled to G-proteins of the G= type, and was decreased 
in the presence of cycloheximide, indicating dependence on 
de-novo protein synthesis. Chemokines also induced the exo- 
cytosis of the N-acetyl-~-D-glucosaminidase which was prevented 
both by receptor blockage with anti-CCR3 and by treatment with 
pertussis toxin. 
Conclusions: Our findings suggest the existence in human 
chondrocytes of a novel catabolic pathway leading to the break- 
down of cartilage matrix components, which is primed by chemo- 
kines and their receptors, setting up an autocrine loop. Since 
chondrocytes obtained from osteoarthritic tissue showed an 
increased expression of CCR3 and possibly of CXCR1 and an 
augmented release of matrix degrading enzymes compared to 
chondrocytes from normal donors, we can also postulate that the 
release of MMP-3 induced by chemokines for homeostatic 
purposes (i.e. the process of cartilage turnover) may become 
excessive and detrimental in OA cartilage and contribute to its 
characteristic degradation. 
TH055 
INTERLEUKIN-17 INDUCES COLLAGENASE-3 PRODUCTION 
IN HUMAN OSTEOARTHRITIC CHONDROCYTES VIA 
AP-1-DEPENDENT PROMOTER TRANSACTIVATION: 
DIFFERENTIAL ACTIVATION OF AP-1 FAMILY MEMBERS BY 
IL-17 AND IL-lp 
M. Benderdour, G. Tardif, J.-P. Pelletier, J. Di Battista, P. Reboul, 
J. MarteI-Peiietier 
Osteoarthritis Research Unit, Centre Hospitafier de I'Universite de 
Montreal, H6pital Notre-Dame, Montreal, Quebec. Canada 
Collagenase-3 is highly expressed in cartilage from arthritic 
patients. Various cytokines and growth factors including IL-ll~ and 
TGF-13 regulate the expression of collagenase-3 in chondrocytes. 
IL-17, a pro-inflammatory c tokine involved in the pathophysiology 
of osteoarthritis (OA), was shown to act on various cartilage 
catabolic processes. We therefore investigated, in human OA 
chondrocytes, the effect of IL-17 on the production of 
collagenase-3, and further examined in a comparative manner the 
IL-17 and IL-113-induced transcription factors mediating the 
up-regulation of this enzyme production. 
In this study, we demonstrated that IL-17 and IL-I~ up-regulated 
both the collagenase-3 mRNA expression and protein synthesis, 
though a higher concentration of IL-17 was required to elicit the 
same effect. Transient transfection experiments of human OA 
chondrocytes with the -133CAT human collagenase-3 promoter 
(containing PEA-3, AP-1 and TATA box), and AP-1 or PEA-3 
mutated promoters revealed that the AP-1 site is essential for 
basal and pro-inflammatory cytokine-induced collagenase-3 pro- 
moter activity, whereas the PEA-3 motif exerts a cooperative 
effect. Electrophoretic mobility gel shift analysis showed that 
binding to the AP-1 site increased by 3- and 4-fold over the control 
level with IL-17 (30 min) and IL-113 (60 min), respectively. Further 
experiments aimed at discriminating between IL-17- and IL-113- 
activated AP-1 binding proteins, revealed a difference within the 
Fos members. IL-17 stimulation of OA chondrocytes resulted in 
FosB activation, whereas IL-113 stimulated c-Fos. Further exper- 
iments revealed a difference in the profile of AP-1 protein activation 
depending on whether the collagenase-3 response of OA chondro- 
cytes to cytokines was high or low. Interestingly, JunB was acti- 
vated only in cells showing a higher collagenase-3 basal level and 
low cytokine inducibility, suggesting this transcription factor protein 
acts as a negative regulator. This was found for both IL-17 and 
IL-113. 
In conclusion, we demonstrated that IL-17 and IL-113 induced 
collagenase-3 production mainly through AP-1 mediated transcrip- 
tional activity, but with differential protein complexes, alluding to 
the possibility that AP-1 proteins play a pivotal role in the different 
cytokine response in terms of collagenase-3 production. The data 
also suggests that the complex formed with FosB translates into a 
weaker response. Furthermore, the JunB protein likely plays a 
rate-limiting step in cytokine-induced collagenase-3 production in 
OA chondrocytes. 
TH057 
ACTIVATION OF PEROXISOME PROLIFERATOR-ACTIVATED 
RECEPTOR 7 SUPPRESSES THE PRODUCTION OF 
DEGRADATIVE FACTORS IN HUMAN CHONDROCYTES AT 
THE TRANSCRIPTIONAL LEVEL 
H. Fahmi, J. A. Di Battista, J.-P. Pelletier, J. C. Fernandes and 
J. MarteI-Pelletier 
Osteoarthritis Research Unit, Centre Hospitalier de I'Universite de 
Montreal, H6pital Notre-Dame, Montreal Quebec, Canada 
Interleukin-1 ]3 (IL-113) is an important mediator of several catabolic 
processes involved in joint destruction characteristic of osteo- 
arthritis. Upon activation by IL-113, chondrocytes produce degrada- 
tive factors, including collagenase-3 (MMP-13) and nitric oxide 
(NO). Given that the peroxisome proliferator-activated receptor y 
(PPARy), a member of the nuclear hormone receptor superfamily 
and involved in adipocyte differentiation and glucose homeostasis, 
has recently been shown to regulate inflammatory responses, we 
investigated the expression and function of this factor in human 
chondrocytes. As such, we examined the effects of PPAR,( 
activation on the IL-113-induced expression and synthesis of 
MMP-13 and NO. 
Treatment of chondrocytes with PPAR 7 ligands BRL 49653 and the 
naturally occurring 15-deoxy-delta12-14-prostaglandin J2 (15d- 
PGJ2) dose-dependently decreased IL-113-induced MMP-13 and 
NO production. The inhibitory effect of PPARy activation was not 
restricted to IL-113 as TNF-c~- and IL-17-induced MMP-13 and NO 
production were also inhibited by 15d-PGJ 2. Northern blot analysis 
revealed that both MMP°13 and the inducible NO synthase (iNOS) 
mRNA levels were inhibited in the presence of 15d-PGJ 2. Further- 
more, 15d-PGJ 2 diminished MMP-13 and iNOS-promoter activity 
(Luciferase reporter system) in transiently transfected human cells. 
Co-transfection of MMP-13 or iNOS promoters with a PPARy 
expression vector greatly accentuated the inhibitory effects of 
15d-PGJ 2. 
The transcription factors AP-1 and NF-KB are believed to mediate 
the IL-113 upregulation of MMP-13 and iNOS promoter activities, 
respectively. Activation of AP-1 and NF-~B-Luciferase reporter 
plasmids by co-transfection with a MEKKI expression vector was 
compromised by the addition of a PPARy expression vector and 
completely blocked by treatment of the transfected cells with 
15d-PGJ 2. 
Taken together, our data suggest that 15d-PGJ~ inhibits MMP-13 
and iNOS expression at the transcriptional level in chondrocytes 
through activation of PPAR 7 with the resultant antagonism of AP-1 
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and NF-~:B transactivation of target promoters. Furthermore, the 
PPAR'( signaling pathway presents a novel target for therapeutic 
intervention in arthritis diseases. 
TH075 
THE INDUCTION OF CELL DEATH IN HUMAN 
OSTEOARTHRITIS CHONDROCY'FES BY NITRIC OXIDE IS 
RELATED TO THE PRODUCTION OF PROSTAGLANDIN E 2 
VIA THE INDUCTION OF CYCLOOXYGENASE-2 
K. Notoya, D. Jovanovic, J. A. Di Battista, J. MarteI-Pelletier, 
F. Mineau, and J.-P. Pelletier 
Osteoarthritis Research Unit, Centre Hospitalier de I'Universite de 
Montreal, HSpital Notre-Dame, Montreal, Quebec, Canada 
There is increasing evidence suggesting that chondrocyte death 
may contribute to the lSrogression of osteoarthritis (OA). This study 
focused on the characterization of signaling cascades during nitric 
oxide (NO)-induced cell death in human OA chondrocytes. 
The NO generator, sodium nitroprusside (SNP) promoted chondro- 
cyte death in association with DNA fragmentation, caspase-3 
activation, and down-regulation of Bcl-2. Both caspase-3 inhibitor 
Z-DEVD-FMK and caspase-9 inhibitor Z-LEHD-FMK prevented the 
chondrocyte death. Blocking the mitogen-activated protein kinase 
(MAPK) pathway by the mitogen-activated protein kinase 1/2 
(MEK1/2) inhibitor PD98059 or p38 kinase inhibitor SB202190 also 
inhibited the SNP-mediated cell death, suggesting possible 
requirements of both extracellular signal-related protein kinase 1/2 
(ERK1/2) and p38 kinase for the NO-induced cell death. Further- 
more, the selective inhibition of cyclooxygenase-2 (COX-2) by 
NS-398 or the inhibition of COX-I/COX-2 by indomethacin blocked 
the SNP-induced cell death. The chondrocyte death induced by 
SNP was associated with an over expression of COX-2 protein as 
determined by Western blotting and an increase in PGE 2 release. 
PD98059 and SB202190, but neither Z-DEVD-FMK nor Z-LEHD- 
FMK, completely inhibited the SNP-mediated PGE 2 production. 
Analysis of interactions between PGE 2 and the cell death showed 
PGE 2 enhanced the SNP-mediated cell death, although PGE 2 
alone did not induce the chondrocyte death. 
These data indicate that NO-induced chondrocyte death signaling 
includes PGE 2 production via COX-2 induction and suggest that 
both ERK1/2 and p38 kinase pathways are upstream signaling of 
the PGE 2 production. The results also demonstrate that exo- 
genous PGE 2 may sensitize human OA chondrocytes to the cell 
death induced by NO. 
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INVOLVEMENT OF TWO KINASE PATHWAYS IN 
HEPATOCYTE GROWTH FACTOR 
COLLAGENASE-3-1NDUCED PRODUCTION IN HUMAN 
OSTEOARTHRITIC CARTILAGE 
P. Reboul, J.-P. Pelletier, G. Tardif, M. Benderdour, J.-M. Cloutier, 
J. MarteI-Pelletier 
Osteoarthritis Research Unit, Centre Hospitafier de I'Universite de 
Montreal, H6pital Notre-Dame, Montreal, Quebec, Canada 
Osteoarthritis (OA) involves both a decreased reparative process 
and an increased degradative phenomenon. Several cytokines 
and growth factors are known to facilitate the repair of articular 
cartilage defects. The growth factor, hepatocyte growth factor 
(HGF), present in OA cartilage is suggested to be involved in the 
cartilage repair process, matrix remodeling and chondrocyte 
migration, leading to structure of articular cartilage. 
Since cell migration is often correlated with metalloprotease 
activity, the effect of HGF on collagenase-3 production was studied 
because of its possible implication in OA cartilage remodeling. 
Since cell migration is often correlated with metalloprotease 
activity, the effect of HGF on collagenase-3 production was studied 
because of its possible implication in OA cartilage remodeling. 
This study showed that HGF stimulates collagenase-3 production 
by OA human chondrocytes at the transcriptional level and that the 
induction of collagenase-3 is mediated by an activation of p42/p44 
MAP kinases as well as SAP/JNK kinases but not by p38 MAP 
kinase. By using specific kinase inhibitors, we found that the 
inhibition of p42/p44 (PD98059) did not affect HGF-induced 
collagenase-3 production in OA chondrocytes. We also demon- 
strated that HGF induced collagenase-3 production via the 
activation of the SAP/JNK kinase pathway was, at least in part, 
mediated via the TRE site in the promoter, and that in the AP°I 
complex, the c-Jun, JunD and Fra-1 are activated. Surprisingly, 
further experiments revealed that the specific p38 MAP kinase 
inhibitor (SB202190) also inhibited collagenase-3 production early 
in the HGF-induced process. The ICso is as low as 25 nM, which is 
unlikely related to p38 MAP kinase inhibition (which is usually in 
the pM range) suggesting the involvement of another kinase 
sensitive to SB202190. 
In summary we showed for the first time that HGF has the ability to 
induce collagenase-3 expression and synthesis in OA chondro- 
cytes. The effect is mediated by kinase cascades involving SAP/ 
JNK and another unidentified kinase. This study provides novel 
information about a new factor, HGF, implicated in the patho- 
physiology of OA and its effect on collagenase-3 production, an 
enzyme possibly involved in OA cartilage remodeling. 
TH092 
MULTINUCLEAR MRI METHODS FOR THE EARLY 
DIAGNOSIS OF OSTEOARTHRITIS 
Erik M. Shapiro', Arijitt Borthakur, Jonathan Kaufman, Sagar 
Kudchodkar, J. Bruce Kneeland, John S. Leigh and Ravinder 
Reddy 
Departments of Chemistry* and Radiology. University of 
Pennsylvania, Philadelphia, PA 
Objective: The goal of this work was to develop magnetic 
resonance imaging (MRI) techniques to measure proteoglycan 
(PG) and water content of articular cartilage, in vivo. 
Background: The earliest stages of osteoarthritis (OA) involve 
the loss of PG from the cartilage matrix and an increase in water 
content. Water content can be directly measured by accurate 
quantitation of the signal in proton density images. As PG is highly 
negatively charged protein aggregates, positively charged sodium 
ions are recruited into the cartilage matrix to maintain electro- 
neutrality, obeying Donnan equilibrium properties. Therefore, a 
loss of PG will result in a loss of sodium ions from the cartilage. We 
have designed novel techniques, using 23Na MRI, which can 
quantitate these physiological changes during the early onset of 
OA. These MRI methodologies can serve as an early diagnostic 
tool, and can be used to evaluate therapeutic efficacy of new 
drugs. 
Methods: Sodium concentration in articular cartilage is a direct 
reflection of PG content. Therefore, 23Na MRI is well suited for 
monitoring PG physiology. These experiments were first verified 
"using both normal and degraded whole bovine patellae, and were 
later applied to the knees of asymptomatic human volunteers. 
Sodium concentration in the patellar cartilage was determined by 
simultaneous imaging of the patellae with four external sodium 
signal calibration phantoms. These phantoms were 10% agarose 
containing varying concentrations of saline. Three dimensional 
23Na MRI data sets and T 1 maps were acquired using a fast 
gradient echo pulse sequence. T2* was obtained from the 
linewidths of the NMR spectra. Corrections in the expression for 
signal intensity for the difference in relaxation times between the 
phantoms and the cartilage allowed a direct fitting of the signal 
intensities of the cartilage to calibration curve. Degradation of the 
bovine cartilage, simulating the early OA state by removing PG, 
was accomplished by immersion of the intact cartilage in various 
concentrations of trypsin. PG depletion was measured by DMMB 
spectrophotometric assays. 
We have also developed 1H based MRI methodologies to 
measure water content in a similar fashion. The six phantoms used 
to calibrate signal intensity were H20/D20, 2% agarose phantoms, 
varying the proportion of H20 from 95% to 70%. Proton density 
imaging and T2 mapping were accomplished using a multi-slice, 
multi-echo spin echo sequence. Verification of the water content 
measurements was accomplished by comparison of the MRI data 
with the physical measurement of water weight difference between 
native and dehydrated cartilage discs. 
Results: Sodium concentrations were found to be non-uniform 
across healthy bovine articular cartilage, ranging from -200 mM at 
the bone/cartilage interface and the surface lamina, to -390 mM at 
the center of the cartilage. The global average of a simulated 
cartilage plug was -320 mM. Water content was highest at the 
surface layer, with a high of 85% to 65% at the bone/cartilage 
interface, yielding a global average of 75%. Degraded cartilage 
displayed significantly lower sodium concentrations corresponding 
well to the degree of PG loss. Sodium concentrations in healthy 
human articular cartilage varied considerably, perhaps indicating 
the presence of early OA in some asymptomatic human volun- 
teers. The same trend of increased sodium concentration in the 
center of the cartilage is present in human cartilage. 
Conclusions: 23Na MRI is a powerful tool for tracking the 
physiological changes of cartilage associated with the early stages 
of OA, particularly the loss of PG. Exploitation of this technique, 
combined with water content mapping and physical thickness 
measurements, can be used as a compelling tool for diagnosing 
OA at an early stage. Furthermore, these techniques hold 
the promise of the ability to monitor the efficacy of potential 
chondroprotective and chondroregenerative agents. 
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RANDOMIZED CONTROLLED CLINICAL TRIAL: 
EFFECTIVENESS OF PHYSIOTHERAPY FOR PATIENTS 
WITH OSTEOARTHRITIS OF THE KNEE 
M. Fransen, J. Crosbie, J, Edmonds 
St George Hospital, Kogarah, Australia 
Aim: To assess the effectiveness of two modes of physiotherapy 
services in terms of pain, physical function and health-related 
quality of life in a pragmatic study using referred patients with OA 
knee. 
Methods: All patients appearing on the physiotherapy outpatient 
waiting list of a large public hospital were invited to participate if 
they were aged at least 50 years and fulfilled ACR clinical criteria 
for the diagnosis of OA knee. More than 90% of eligible patients 
agreed to participate as participation resulted in a 67% chance of 
evading the usual 4-8 week waiting time for chronic conditions. A 
total of 126 patients, were randomized into one of three 8-week 
allocations: individual physiotherapy treatments, small group- 
format exercise program and waiting list control. To increase 
generalisability of the results, twenty-eight physiotherapists were 
involved in providing treatments. Assessments: baseline (mean of 
2 assessments pre-randomisation); post-treatment (week 8); two- 
month follow-up (week 16). Assessments consisted of self- 
reported pain and physical function (WOMAC), health-related 
quality of life (SF-36: Physical Component Summary (PCS) and 
Mental Component Summary (MCS)) and objective measures of 
physical performance (gait analysis and peak isometric muscle 
strength). Analysis was 'per intention to treat'. 
Results: Loss to follow-up at week 8 (5.5%), at week 16 (15%). 
For all outcomes, positive changes are improvements. Both forms 
of physiotherapy resulted in significant improvements (p<0.05) in 
all outcome measures with significance adjusted for baseline 
differences between the groups and with decreased consumption 
of daily simple analgesia or NSAIDs. The changes affected by the 
physiotherapy treatment (above the waiting list control group), as 
assessed with the standardised response mean (SRM), would be 
rated as small to medium (Table). 
Age 
Sex (% female) 
BMI 
Symptoms 





Knee extensors (N) 
Knee flexors (N) 
Fast speed 
(cm sec- 1) 
Fast cadence 
(steps.min -1) 
Fasl stride lenglh (cm) 
Table. Physiotherapy versus Control 
Physiotherapy (n=83) Controls (n =43) 
Mean change SRM 
(95% C[) 
-1 5 ( -5  6,2.4) 65  
-0.1 ( -39 .  3.7) .49 
0.5 (- 1.5. 2.3) .36 
-0.7 (- 1.6, 0 5) .51 
-2  4 ( -9 .2 .45)  46 
-0.6 ( -56 ,  52)  46  
0.4 (- 1.3, 2.1) .58 
0.3 ( -06.  1 3) 26  
"[WOMAC (lO0=no pain/difficulty. 0=exleme pain/difficulty) SF-36 (populalion mean=50)) 
The improvements in self-reported pain and physical function were 
substantiated by correlated improvements in the objective 
measures of physical performance, and then most strongly with 
changes in knee extensor isometric strength (Rho=0.42, 0.38 for 
pain, physical function respectively). There were no significant 
differences in clinical effectiveness between the two modes of 
physiotherapy for any of the outcomes. Improvements gained were 
maintained at the 2-month follow-up assessment without further 
changes in consumption of simple analgesia or NSAIDs. 
Conclusion: Physiotherapy, either as an individually delivered 
treatment or in a small group-format exercise program, is an 
effective intervention with at least a two-month sustainability. 
13. 43. 43 








1282 (19.5) 4.7 (3.0, 6.3) 
Baseline 
mean (sd) 
66 9 (7 9) 
76% 
30.0 (5.2) 
130.3 (22.2) 9.4 (-1.3, 2.0) 
Mean change Baseline 




12, 49. 40 
10.6(63. 150) 658(194)  
77  (4.2, 11 2) 60.0 (20.5) 
3.6 (1.9.5.3) 34.8 (8.2) 
2,0 (0.8.3.3) 42.9 (7.0) 
10.8 (4.3. 17.3) 173.3 (67.1) 
8.4 (4,0, 12.7) 1001 (40.9) 
7.1 (4.7.9 4) 127.8(24.1) 
19(07 ,3 .2 )  1176(10.3) 
,55 
